BPC-157 5mg / 10mg

BPC-157 is commonly classified as a regenerative research peptide, frequently discussed within Australian peptide research communities alongside recovery and tissue-related peptide research, cellular signalling pathways, gut-related peptide studies, and peptide receptor activity. (!) Learn more in our regenerative peptide guide view here.

Body protection compound, abbreviated BPC, takes its name from the gastric protein the peptide was derived from. BPC-157 is a 15-amino-acid fragment of that protein — body protection compound 157, BPC 157 and BPC-157 all refer to the same research peptide.

BPC-157 is short for body protection compound 157. It is written variously as BPC 157, BPC157 and BPC-157, and appears in research literature as pentadecapeptide BPC 157 or PL 14736. It is also frequently mistyped as BOC 157, BP 157 or BCP157 — all of these refer to the same research peptide.

Yes — PhaseOne has BPC-157 for sale online in 5mg and 10mg vials, shipped Australia-wide. Online listings for BPC-157 appear in several formats, including capsule and oral preparations sold by other suppliers. PhaseOne supplies only the lyophilised research-grade powder, with a batch Certificate of Analysis so ≥99% HPLC purity can be verified on arrival.

BPC-157 is a pentadecapeptide derived from a gastric protein, studied for angiogenesis and gut-lining signalling. TB-500 is a synthetic fragment of thymosin beta-4, studied for cell migration and actin regulation. They are structurally unrelated, which is why the two are often studied alongside each other. (!) View our TB-500 or read the regenerative peptide guide.

Wolverine stack is an informal nickname for BPC-157 combined with TB-500 — a pairing common enough in research discussion to have acquired its own name. PhaseOne supplies the two as a single blended vial. (!) View our BPC-157 + TB-500 Blend.

Both are short peptides studied within inflammatory-pathway research, but they originate differently — BPC-157 from a gastric protein, KPV from the terminal tripeptide sequence of alpha-MSH. PhaseOne supplies both. (!) View our KPV.

PhaseOne ships BPC-157 Australia-wide for research use, dispatched locally with tracking, in 5mg and 10mg vials. Every vial carries a batch-specific Certificate of Analysis verifying ≥99% HPLC purity.

PhaseOne prices BPC-157 at A$39.99 for a 5mg vial and A$63.99 for 10mg, with the batch Certificate of Analysis included at no extra cost. The BPC-157 + TB-500 blend starts at A$87.99.

No. BPC-157 is not registered on the ARTG and is not approved for supply as a medicine in Australia, so Chemist Warehouse and other Australian chemists do not stock it. It is supplied as a research compound through research suppliers instead.

Published BPC-157 research has expanded significantly in recent years, with growing scientific interest in cellular signalling, tissue-related and recovery peptide pathways, gut-related peptide signalling, peptide receptor interactions, and metabolic signalling pathways. BPC-157 remains one of the most widely searched research peptides in Australia, as additional clinical and laboratory findings continue to emerge. (!) Explore more BPC-157 peptide research guides view here.

BPC-157 is supplied as a lyophilised powder for improved stability during storage and shipping across Australia. Unreconstituted vials should be kept refrigerated and protected from direct light, and are commonly reconstituted using bacteriostatic water prior to research preparation. (!) Read our reconstitution guide or bacteriostatic water guide.

As interest in research peptides grows across Australia, transparency and third-party testing have become increasingly important to Australian peptide buyers. All PhaseOne research peptides are supported by third-party HPLC testing, verified COA reporting, research-grade manufacturing standards, and Australia-wide access. (!) View our COA library.

HPLC testing refers to High Performance Liquid Chromatography, an analytical method used to verify peptide purity and compound identity - a standard PhaseOne applies to every research peptide sold in Australia.

Yes - BPC-157 is frequently studied alongside TB-500 for complementary recovery and tissue-related research, and is available as a combined preparation. (!) View our TB-500 or BPC-157 + TB-500 Blend.